Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder

NCT00203528 is registered in ClinicalTrials.gov with Tuscaloosa Research & Education Advancement Corporation as lead sponsor.

NCT NCT00203528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00203528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder
Lead sponsor
Tuscaloosa Research & Education Advancement Corporation
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2004
Completion date
February 28, 2007
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, substance abuse